Evobrutinib and its Impurities

Evobrutinib is a Bruton's tyrosine kinase Inhibitor discovered by Merck, that has clinical potential across multiple autoimmune conditions. Reference standards of Evobrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.